Assessing and Addressing Quality of Life and Patient-Reported Outcomes: Creating Shared Decision-Making for Hepatitis B Management and Treatment

Nov 10 2025
Convention Center: Room 201, Level 2
9:45 AM - 10:45 AM

World Class Speakers

Ravshan Yakubov, MBA, CPA, CA
Presenter

Ravshan Yakubov, MBA, CPA, CA

Patient with Hep B/D
Zobair M Younossi, MD, MPH, FAASLD
Presenter

Zobair M Younossi, MD, MPH, FAASLD
Su H Wang, MD, MPH, FACP
Presenter

Su H Wang, MD, MPH, FACP
Wendy Lo
Presenter

Wendy Lo

Wendy Lo Consulting LLC
Donna M. Evon, PhD
Presenter

Donna M. Evon, PhD
Robert Gish
Moderator

Robert Gish

Robert G Gish Consultants LLC
Chari Cohen
Moderator

Chari Cohen

Description

Panelists highlight the perspectives of providers and people living with hepatitis B regarding strategies to assess and address patient-reported outcomes, and cultivate shared decision-making that is informed by scientific evidence, provider expertise, and patient preferences. The diverse panel includes representatives of nonprofit organizations, health systems, academic institutions, and patient advocacy groups. A question-and-answer period follows speaker presentations.

Journey Maps

Presentations

9:45 AM - 9:55 AM
Nov 10 2025
Washington, D.C.

The Impacts of Stigma and Discrimination on People Living With Hepatitis B

Ravshan Yakubov, MBA, CPA, CA, Presenter
Hepatitis
9:55 AM - 10:05 AM
Nov 10 2025
Washington, D.C.

Role of Treatment on Patient-Reported Outcomes in Hepatitis B

Zobair M Younossi, MD, MPH, FAASLD, Presenter
Hepatitis
10:05 AM - 10:15 AM
Nov 10 2025
Washington, D.C.

Strategies for Shared Decision-Making in Hepatitis B Management and Treatment

Su H Wang, MD, MPH, FACP, Presenter
Hepatitis
10:15 AM - 10:25 AM
Nov 10 2025
Washington, D.C.

Costs to Patients and Family Related to Hepatitis B Management and Treatment

Wendy Lo, Presenter
Hepatitis
10:25 AM - 10:35 AM
Nov 10 2025
Washington, D.C.

Measuring the Quality of Life Impact of Hepatitis B

Donna M. Evon, PhD, Presenter
Hepatitis

Objectives

  • Relate the perspectives of people living with hepatitis B regarding treatment eligibility and options, quality of life and important patient-reported outcomes, treatment adherence, and the impacts of stigma and discrimination.
  • Identify strategies for assessing hepatitis B quality of life impact in the clinical setting.
  • Discuss strategies for using shared decision-making models to enhance provider-patient communication and make hepatitis B management and treatment decisions.